Cargando…

CDH13 promoter region is specifically methylated in poorly differentiated colorectal cancer

It has recently become clear that CDH13 (H-cadherin, T-cadherin) expression is frequently silenced by aberrant methylation in colorectal cancers and adenomas. In this study, we investigated the methylation status of CDH13 gene and detected aberrant promoter methylation in 27 of 84 (32%) colorectal c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hibi, K, Nakayama, H, Kodera, Y, Ito, K, Akiyama, S, Nakao, A
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2004
Materias:	Molecular and Cellular Pathology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2409627/ https://www.ncbi.nlm.nih.gov/pubmed/14997203 http://dx.doi.org/10.1038/sj.bjc.6601647

Ejemplares similares

Methylation pattern of CDH13 gene in digestive tract cancers
por: Hibi, K, et al.
Publicado: (2004)

CpG island methylation is a common finding in colorectal cancer cell lines
por: Suter, C M, et al.
Publicado: (2003)

Both high intratumoral microvessel density determined using CD105 antibody and elevated plasma levels of CD105 in colorectal cancer patients correlate with poor prognosis
por: Li, C, et al.
Publicado: (2003)

Pathological features and genetic alterations in colorectal carcinomas with characteristics of nonpolypoid growth
por: Kaneko, K, et al.
Publicado: (2004)

RARRES3 expression positively correlated to tumour differentiation in tissues of colorectal adenocarcinoma
por: Shyu, R-Y, et al.
Publicado: (2003)

Abnormal Fhit expression is an independent poor prognostic factor for cervical cancer
por: Takizawa, S, et al.
Publicado: (2003)

Correlation of elevated level of blood midkine with poor prognostic factors of human neuroblastomas
por: Ikematsu, S, et al.
Publicado: (2003)

High expression of telomerase is an independent prognostic indicator of poor outcome in hepatoblastoma
por: Hiyama, E, et al.
Publicado: (2004)

Plasminogen activator inhibitor-1 as a potential marker for the malignancy of colorectal cancer
por: Sakakibara, T, et al.
Publicado: (2005)

Low expression of polypeptide GalNAc N-acetylgalactosaminyl transferase-3 in lung adenocarcinoma: impact on poor prognosis and early recurrence
por: Gu, C, et al.
Publicado: (2004)

No major tumorigenic role for β-catenin in serrated as opposed to conventional colorectal adenomas
por: Yamamoto, T, et al.
Publicado: (2003)

Coexpression of epidermal growth factor receptor with related factors is associated with a poor prognosis in non-small-cell lung cancer
por: Swinson, D E B, et al.
Publicado: (2004)

CpG island methylation status and mutation analysis of the RB1 gene essential promoter region and protein-binding pocket domain in nervous system tumours
por: Gonzalez-Gomez, P, et al.
Publicado: (2003)

Expression of high-mobility-group-protein HMGI-C mRNA in the peripheral blood is an independent poor prognostic indicator for survival in metastatic breast cancer
por: Langelotz, C, et al.
Publicado: (2003)

Human kallikrein gene 13 (KLK13) expression by quantitative RT–PCR: an independent indicator of favourable prognosis in breast cancer
por: Chang, A, et al.
Publicado: (2002)

Prognostic impact of matched preoperative plasma and serum VEGF in patients with primary colorectal carcinoma
por: Werther, K, et al.
Publicado: (2002)

Allelic loss at 19q12 and Xq11–12 predict an adverse clinical outcome in patients with mucinous ovarian tumours of low malignant potential
por: Nakayama, K, et al.
Publicado: (2004)

Nuclear β-catenin expression is closely related to ulcerative growth of colorectal carcinoma
por: Chiang, J M, et al.
Publicado: (2002)

Specific T-cell immunity against Ki-ras peptides in patients with pancreatic and colorectal cancers
por: Shono, Y, et al.
Publicado: (2003)

Cimetidine modulates the antigen presenting capacity of dendritic cells from colorectal cancer patients
por: Kubota, T, et al.
Publicado: (2002)

Expression of basic fibroblast growth factor is associated with poor outcome in non-Hodgkin's lymphoma
por: Pazgal, I, et al.
Publicado: (2002)

Lactate dehydrogenase-5 (LDH-5) overexpression in non-small-cell lung cancer tissues is linked to tumour hypoxia, angiogenic factor production and poor prognosis
por: Koukourakis, M I, et al.
Publicado: (2003)

The transcription factor DEC1 (stra13, SHARP2) is associated with the hypoxic response and high tumour grade in human breast cancers
por: Chakrabarti, J, et al.
Publicado: (2004)

CpG methylation of MGMT and hMLH1 promoter in hepatocellular carcinoma associated with hepatitis viral infection
por: Matsukura, S, et al.
Publicado: (2003)

Methylation status of p14ARF and p16INK4a as detected in pancreatic secretions
por: Klump, B, et al.
Publicado: (2003)

Genomic analysis reveals RhoC as a potential marker in hepatocellular carcinoma with poor prognosis
por: Wang, W, et al.
Publicado: (2004)

Differential SPARC mRNA expression in Barrett's oesophagus
por: Brabender, J, et al.
Publicado: (2003)

Quantitative analysis of human kallikrein gene 14 expression in breast tumours indicates association with poor prognosis
por: Yousef, G M, et al.
Publicado: (2002)

Prognostic significance of dysadherin expression in advanced colorectal carcinoma
por: Aoki, S, et al.
Publicado: (2003)

Caveolin-1 overexpression predicts poor disease-free survival of patients with clinically confined renal cell carcinoma
por: Campbell, L, et al.
Publicado: (2003)

Differential gene expression profiles of radioresistant oesophageal cancer cell lines established by continuous fractionated irradiation
por: Fukuda, K, et al.
Publicado: (2004)

Intraepithelial CD8(+) T-cell-count becomes a prognostic factor after a longer follow-up period in human colorectal carcinoma: possible association with suppression of micrometastasis
por: Chiba, T, et al.
Publicado: (2004)

Liver fatty acid binding protein expression in colorectal neoplasia
por: Lawrie, L C, et al.
Publicado: (2004)

Cytokeratin 7 and 20 staining for the diagnosis of lung and colorectal adenocarcinoma
por: Kummar, S, et al.
Publicado: (2002)

Inactivation of class II transactivator by DNA methylation and histone deacetylation associated with absence of HLA-DR induction by interferon-γ in haematopoietic tumour cells
por: Morimoto, Y, et al.
Publicado: (2004)

Both gene expression for orotate phosphoribosyltransferase and its ratio to dihydropyrimidine dehydrogenase influence outcome following fluoropyrimidine-based chemotherapy for metastatic colorectal cancer
por: Ichikawa, W, et al.
Publicado: (2003)

Molecular mechanisms of action and prediction of response to oxaliplatin in colorectal cancer cells
por: Arango, D, et al.
Publicado: (2004)

Identification of two contiguous minimally deleted regions on chromosome 1p36.31–p36.32 in oligodendroglial tumours
por: Dong, Z, et al.
Publicado: (2004)

Nuclear BAG-1 expression reflects malignant potential in colorectal carcinomas
por: Kikuchi, R, et al.
Publicado: (2002)

Tissue levels of active matrix metalloproteinase-2 and -9 in colorectal cancer
por: Waas, E T, et al.
Publicado: (2002)

Cannot write session to /tmp/vufind_sessions/sess_jup8uedbrm8077hvtp6nioh62p